A refresher on the rare blood clot condition known as VIPIT Health Canada investigating blood clot reports after U.S. pauses J&J vaccine Health Canada conducting safety review of Xeljanz and Xeljanz XR Vancouver funds permanent position to lead overdose response team Canadian Medical Association hopes federal budget will address primary care needs Management of postherpetic neuralgia Postherpetic neuralgia (PHN) is one of the few chronic pain conditions that we can often pre-emptively avoid. Health Canada recalls masks containing graphene as it assesses risks to people What we know about J&J's single dose vaccine, set to arrive at the end of April Genitourinary syndrome of menopause (GSM) Pharmacists can help with identification, management and patient education New warning about risk for Guillain-Barré syndrome after Shingrix administration US Food and Drug Administration requires warning about GBS be added to the prescribing information for Shingrix (herpes zoster vaccine) First Previous 90 91 92 93 94 Next Last
